Competitive Intelligence in Pharma and Biotech

Why AlphaSense is the Leading Comp Intel Tool For Biopharma

AlphaSense is a leading provider of competitive intelligence, aggregating 10,000+ high-quality content sources that cover hundreds of thousands of public companies and over 1.4 million private companies — all in a single platform.

Our platform is consistently ranked as an industry leader by G2 and TrustRadius, and was recognized as one of the top 50 AI companies by Forbes.

Competitive strategists and decision makers in the pharmaceutical and biotechnology sectors have access to exclusive competitive data ordinarily found in disparate locations and often behind expensive paywalls. With AlphaSense, organizations can conduct comprehensive quantitative and qualitative market research that results in smarter strategic decision-making.

AlphaSense aggregates premium content from across the key perspectives of research, all indexed and easily searchable.

AlphaSense also saves you hours of research time by centralizing the insights you need and delivering them to you with intelligent, AI technology — maximizing confidence and minimizing informational blind spots. Automated alerts and customized watchlists ensure you never miss an update from the companies and industries you most care about. Advanced filtering features help you easily navigate through the specific types of content you need for more granular research.

Here’s how AlphaSense supports you in every step of your competitive intelligence journey.

How AlphaSense Takes Your Competitive Intelligence Further

Leading healthcare and pharma companies trust AlphaSense as their all-in-one market intelligence tool that helps them maximize efficiency, keep on pace with innovation, and stay on the leading edge.

Premium External Market Insights

Our library of qualitative content includes:

• Over 1,700 broker sources, including Wall Street Insights, a premier and exclusive equity research collection for corporate teams (healthcare included)
• Expert calls, which includes over 240,000 interviews with pre-qualified experts (including doctors, customers, competitors, and industry experts), as well as the ability to conduct your own 1:1 calls with 70% cost savings compared with traditional expert networks
• Regulatory documents from publications including ClinicalTrials.gov, FDA, EMA, MedlinePlus, and PubMed
• Company documents and filings, including earnings transcripts, company presentations, SEC and global filings, ESG reports, and press releases
• News outlets including medical journals, RSS feeds, business news, and market news
• Company and competitor websites

Generative Search

Generative Search allows users to ask natural-language questions and source intelligence at scale from across premium external content, internal knowledge, and quantitative data sources.

With Deep Research mode, users can automate the creation of in-depth analysis about companies, trends, or industry topics. The model conducts dozens of searches, parses through thousands of potentially relevant results, and reasons over all of it to produce comprehensive, detailed analysis about any topic — in a fraction of the time it would take a human.

For example, ask Generative Search: “Analyze the adoption and implementation of AI-driven drug discovery within oncology, specifically comparing Roche, AstraZeneca, and Eli Lilly.” In return, you will get:

• Comparative analysis of tech investment and adoption
• Analysis of partnerships, acquisitions, and research alliances
• Detailed insights into competitive differentiation by technology leadership

Generative Grid

Generative Grid applies multiple genAI prompts to many documents at the same time to quickly provide organized answers to research questions at scale, in an easy-to-read table format. This enables clients to summarize documents using pre-built criteria to save time when executing repeatable workflows.

For example, you can use our Customized Life Sciences Competitive Analysis template that inputs earnings calls, analyst transcripts, internal battlecards, investor presentations, and clinical trial updates. In return, you will get a grid that shows, for each competitor:

• Clinical trial success rates and FDA approval timelines
• Market share, revenue, and growth trajectories
• Key quotes and positioning from leadership teams

Smart Summaries

Every earnings transcript in AlphaSense features an AI-generated Smart Summary, which creates a tearsheet of key takeaways, analyst Q&A, and the most critical topics discussed in each call. AlphaSense users leverage Smart Summaries during earnings season to extract the most crucial insights from each call in just minutes, ensuring a comprehensive and timely view of key insights.

Semantic Search

Instead of digging through fragmented reports and alerts, you can rely on our semantic search to make sure you never miss out on critical insights. Our AI search technology automatically recognizes what you are looking for and delivers the results that match the intent behind your query. This means you don’t have to do multiple searches to get the results you need, and you can be more confident in the comprehensiveness and accuracy of your research.

For example, searching “medtech” will also surface results for “medical technology” and “healthcare technology.” Searching “Ozempic” will also surface results for “Wegovy”, “Rybelsus”, and “semaglutide.” Our synonym recognition technology mitigates the risk of missing critical insights or information sources.

Sentiment Analysis

Our sentiment analysis and natural language processing (NLP) technology analyzes how the market feels about a given company, industry, or topic and color-codes positive and negative sentiment for easy recognition as you browse documents and search results. Sentiment analysis is instrumental in earnings research, as it uncovers subtle shifts in a competing company’s messaging on relevant topics and themes.